MedTrace Logo

ETNA-MS Device Validation Study

NCT06256731 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2026-04-01

No results posted yet for this study

Summary

The overarching goal of this research protocol is to validate the effectiveness of Innodem's ETNA-MS device in informing clinicians on the disability status of Multiple Sclerosis (MS) patients. Effectiveness of the device will be assessed by the level of agreement between the EDSS estimated by the device and the actual scores measured by the neurologist in-person assessments.

Conditions

Interventions

DEVICE

Eye-Tracking

Eye-tracking technology and algorithms used to successfully capture and track eye movements using an electronic tablet and the embedded camera of the device.

Sponsors & Collaborators

  • Syneos Health

    collaborator OTHER

  • Innodem Neurosciences

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-12-12
Primary Completion
2024-06-12
Completion
2024-06-12

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06256731 on ClinicalTrials.gov